It is the most common claim in the peptide industry: “98% pure.”
You see it stamped on websites, printed on labels, and highlighted on Certificates of Analysis (CoAs). For most buyers, that number is enough. It sounds close enough to 100% to feel safe.
But recently, the scientific and medical communities have started asking a much more important question. In a viral analysis published earlier this month, Stuart Phillips, a Tier 1 Canada Research Chair at McMaster University, pointed out that many gray-market vendors offer assurances of 98% purity, but then asked the critical question:
“What exactly is the other 2%?”
It’s a question that cuts to the core of peptide safety. Because when you are dealing with potent biological molecules, 2% of the wrong thing can be a very big deal.
Here is what is actually hiding in that missing 2%, why basic testing can’t see it, and how to verify what is really in your vial.
The Illusion of the Single Number
When a gray-market vendor posts a CoA claiming 98% purity, they are almost always relying on a single analytical technique: High-Performance Liquid Chromatography with an Ultraviolet detector (HPLC-UV).
HPLC-UV is a powerful tool, but it has a specific limitation: it measures relative area, not identity.
Imagine looking at a shadow on a wall. You can tell how big the shadow is, but you can’t necessarily tell what is casting it. HPLC-UV works similarly. A chromatogram might show one massive peak that makes up 98% of the total area, and two tiny peaks that make up 1% each.
The test tells you the size of the peaks. It tells you absolutely nothing about what those smaller peaks actually are.
Are they harmless residual salts from the manufacturing process? Or are they broken, mutated peptide chains that will bind to the wrong receptors in your body? Basic HPLC-UV cannot tell the difference.
The Five Families of Peptide Impurities
To understand what lives in that 2%, you have to understand how synthetic peptides are made. They are built one amino acid at a time, usually on a solid resin. It is a complex chemical process, and at every step, the chemistry can fail.
These failures don’t disappear. They ride along in the final powder as “peptide-related impurities.” Regulatory agencies like the EMA and FDA group these into several recognizable families:
1. Deletion Sequences
This happens when an amino acid simply fails to attach during the synthesis process, but the chain keeps growing afterward. The result is a peptide that is missing one crucial link. It might look similar to the intended peptide, but missing a single amino acid can completely change how the molecule interacts with the body.
2. Truncations
Sometimes, the peptide chain just stops growing early. If you are trying to build a 30-amino-acid chain and it stops at 25, you have a truncated impurity.
3. Insertions
If the synthesis equipment isn’t washed out perfectly between steps, an extra amino acid can sneak into the chain. Now your peptide is one link too long.
4. Isomers and Oxidation
This is where the chemistry gets truly sneaky. Sometimes the peptide has the exact right number of amino acids, but they have bent into the wrong shape (isomers) or reacted with oxygen in the air (oxidation). They weigh exactly the same as the correct peptide, making them incredibly hard to detect, but they function differently.
5. Dimers and Aggregates
Sometimes, two peptide chains will covalently bond to each other, creating a “dimer” (two peptides stuck together). This is a significant issue because the immune system is highly sensitive to large, repetitive structures. Injecting dimers increases the risk of triggering an unwanted immune response.
A Tale of Two Vials
Let’s look at a practical example of why knowing the identity of that 2% matters.
Imagine two vials of the same peptide. Both come with a CoA that says “98% pure.”
Vial A: Advanced testing reveals that the remaining 2% is residual acetate—a completely harmless, inert salt left over from the purification process.
Vial B: Advanced testing reveals that the remaining 2% is a truncated peptide. This broken chain acts as a partial agonist, meaning it binds to receptors in the body but sends the wrong signal.
Both vials are mathematically “98% pure.” But Vial A is a clean, safe research chemical. Vial B contains a biologically active contaminant. Same number. Different drug. Different outcome.
This is exactly why the FDA and EMA require pharmaceutical manufacturers to strictly identify any peptide impurity present above 0.5%. You cannot just say “it’s 98% pure” and walk away. You have to name the 2%.
The Vanguard Verification Stack
If basic HPLC-UV can’t tell you what the 2% is, how do you find out? You need orthogonal analysis—using multiple, different types of high-end equipment to look at the sample from different angles.
At Vanguard Laboratory, we don’t just measure the size of the shadow. We turn on the lights.
We use Liquid Chromatography-Mass Spectrometry (LC-MS) to get the exact molecular weight of every single peak. If there is a deletion sequence, the mass spec will catch it.
We use Size-Exclusion Chromatography (SEC) to separate molecules by their physical size, allowing us to spot dimers and aggregates that could cause immune reactions.
We perform Endotoxin (LAL/rFC) testing to ensure the sample hasn’t been contaminated by dangerous bacterial byproducts, and Heavy Metals (ICP-MS) testing to ensure no toxic elements sneaked in during manufacturing.
The End of “Grading Your Own Paper”
The recent joint white paper from the ECRI and the Institute for Safe Medication Practices (ISMP) issued a stark warning about compounded wellness peptides, noting that gray-market testing has found purity ranging from a terrifying 5% up to 75%.
The root of this problem is structural. Too many vendors are acting as their own “third-party” labs, issuing their own CoAs.
The only structural fix is ISO 17025 accreditation. This international standard guarantees impartiality. It means the laboratory testing the peptide has no financial stake in the result, and their analytical methods are rigorously audited by an external body.
When you see a CoA, the first question shouldn’t be “is it 98%?” The first question should be: “Who tested this, and did they identify the other 2%?”
With Vanguard Laboratory, you never have to guess. Our Verified by Vanguard program delivers live, unalterable PDF certificates of analysis that provide total transparency. We don’t just give you a number. We give you the truth.
Vanguard Laboratory is an ISO 17025 accredited analytical testing facility specializing in peptide verification, safety, and purity analysis.